Literature DB >> 10750600

A prospective study of physical activity and risk of prostate cancer in US physicians.

S Liu1, I M Lee, P Linson, U Ajani, J E Buring, C H Hennekens.   

Abstract

BACKGROUND: Exercise can suppress androgen production and may thus decrease the risk of prostate cancer. However, findings from epidemiological studies assessing physical activity and risk of prostate cancer are inconsistent.
METHODS: We prospectively examined the association between physical activity and prostate cancer risk in the Physicians' Health Study (PHS), a randomized trial of low-dose aspirin and beta-carotene among 22,071 men aged 40-84 without self-reported myocardial infarction, stroke and cancer. At baseline in 1982, men were asked about the frequency of exercise vigorous enough to work up a sweat. Physical activity was assessed in a similar fashion again at 36 months of follow-up.
RESULTS: During 11.1 years of follow-up (258 779 person-years), 982 cases of prostate cancer occurred and were confirmed by medical record review. After adjustment for potential confounding factors (including age, height, randomized treatment assignment, smoking status, alcohol intake, use of multivitamins, history of diabetes, history of hypertension and history of high cholesterol), the relative risks for prostate cancer associated with exercise vigorous enough to work up a sweat were 1.0 (referent) for frequency less than once per week, 1.02 (95% CI: 0.82-1.26) for once per week, 1.07 (95% CI: 0.90-1.27) for 2-4 times per week, and 1.11 (95% CI: 0.90-1.36) for 5+ times per week. Across all subgroups of men categorized by age, body mass index, smoking status, alcohol intake, use of multivitamins, history of diabetes, history of hypertension and history of high cholesterol, there were no significant associations between frequency of exercise vigorous enough to work up a sweat and prostate cancer risk. After excluding cases of prostate cancer that occurred during the first 36 months of follow-up, again, there was no significant association. Combining physical activity assessments at baseline and at 36 months also yielded no significant association with prostate cancer risk.
CONCLUSIONS: These observational data from the Physicians' Health Study do not support the hypothesis that increased physical activity reduces the risk of prostate cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10750600     DOI: 10.1093/ije/29.1.29

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  9 in total

Review 1.  Behavior matters.

Authors:  Edwin B Fisher; Marian L Fitzgibbon; Russell E Glasgow; Debra Haire-Joshu; Laura L Hayman; Robert M Kaplan; Marilyn S Nanney; Judith K Ockene
Journal:  Am J Prev Med       Date:  2011-05       Impact factor: 5.043

Review 2.  [Epidemiological evidence for preventing prostate cancer by physical activity].

Authors:  Hans-Christian Heitkamp; Ivan Jelas
Journal:  Wien Med Wochenschr       Date:  2012-10-12

Review 3.  Physical Activity and Prostate Cancer: An Updated Review.

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2017-06       Impact factor: 11.136

4.  Exercise in cancer.

Authors:  P Rajarajeswaran; R Vishnupriya
Journal:  Indian J Med Paediatr Oncol       Date:  2009-04

Review 5.  Exercise and prostate cancer.

Authors:  Dorothea C Torti; Gordon O Matheson
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 6.  Prostate-specific antigen and detection of prostate cancer: What have we learned and what should we recommend for screening?

Authors:  Christopher L Amling
Journal:  Curr Treat Options Oncol       Date:  2006-09

Review 7.  Assessment of physical activity and energy expenditure in epidemiological research of chronic diseases.

Authors:  Ylva Trolle Lagerros; Pagona Lagiou
Journal:  Eur J Epidemiol       Date:  2007-06-29       Impact factor: 12.434

8.  Physical activity and risk of cancer in middle-aged men.

Authors:  S G Wannamethee; A G Shaper; M Walker
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

9.  Estimated prevalence and risk factor for age-related maculopathy.

Authors:  Mi In Roh; Ji Hyun Kim; Suk Ho Byeon; Hyoung Jun Koh; Sung Chul Lee; Oh Woong Kwon
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.